Last reviewed · How we verify

NCT04049422: liquidNodule

Pulmonary Nodule Cohort

Not yet recruiting Last updated 8 August 2019
What this trial tests

trial in Pulmonary Nodule, Solitary in 1,000 participants. Not yet recruiting.

Timeline
6 August 2019
Primary endpoint
31 July 2024
31 July 2029

Quick facts

Lead sponsorSeoul National University Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,000
Start date6 August 2019
Primary completion31 July 2024
Estimated completion31 July 2029

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Pulmonary Nodule, Solitary or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to identify the clinical features of pulmonary nodules and establish a cohort to identify biomarkers for lung cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pulmonary Nodule, Solitary

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04049422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing